BP Lukert - Southern Medical Journal, 1992 - journals.lww.com Glucocorticoid-Induced Osteoporosis * BARBARA P. LUKERT, MD, Kansas City, Kan
ABSTRACT: The incidence of osteoporosis in patients receiving long-term
glucocorticoid therapy is 30% to 50%. Trabecular bone is lost more rapidly ... Cited by 979 - Related articles - BL Direct - All 8 versions
AD Adinoff, JR Hollister - New England Journal of Medicine, 1983 - content.nejm.org To study the association between bone disease and long-term steroid
administration in asthmatics, we reviewed the hospital records of 128 patients
over 40 years of age who had taken daily or alternate-day adrenal ... Cited by 473 - Related articles - All 3 versions
P Sambrook, J Birmingham, P Kelly, S … - New England Journal of Medicine, 1993 - content.nejm.org Methods One hundred three patients starting long-term corticosteroid therapy
were randomly assigned to receive 1000 mg of calcium per day orally and either
calcitriol (0.5 to 1.0 µg per day orally) plus salmon calcitonin (400 IU ... Cited by 402 - Related articles - BL Direct - All 8 versions
- ►psu.edu [PDF] JD Adachi, WG Bensen, J Brown, D Hanley, A … - The New England journal of medicine, 1997 - nejm.highwire.org Background and Methods Osteoporosis is a recognized complication of
corticosteroid therapy. Whether it can be prevented is not known. We conducted a
12-month, randomized, placebo-controlled study of intermittent etidronate ... Cited by 579 - Related articles - BL Direct - All 9 versions
- ►uic.edu [PDF] KG Saag, R Emkey, TJ Schnitzer, JP Brown, F … - New England Journal of Medicine, 1998 - content.nejm.org ABSTRACT Background Osteoporosis is a common compli- cation of long-term
glucocorticoid therapy for which there is no well-proved preventive or
restorative treatment. Methods We carried out two 48-week, random- ized, ... Cited by 736 - Related articles - BL Direct - All 10 versions
Y Suzuki, Y Ichikawa, E Saito, M Homma - Metabolism: clinical and experimental, 1983 - ncbi.nlm.nih.gov Parathyroid function and calcium metabolism were studied in 44 patients under
glucocorticoid therapy (steroid group) and in 25 control subjects. Nephrogenous
cAMP and serum immunoreactive parathyroid hormone levels in the steroid ... Cited by 203 - Related articles
BA Julian, DA Laskow, J Dubovsky, EV … - New England Journal of Medicine, 1991 - content.nejm.org BACKGROUND. Osteopenia is a major complication of renal transplantation.
Immunosuppressive regimens including cyclosporine, which permit the use of lower
doses of glucocorticoids, may reduce glucocorticoid-induced osteopenia. ... Cited by 409 - Related articles - All 5 versions
BP Lukert, BE Johnson, RG Robinson - J Bone Miner Res, 1992 - grande.nal.usda.gov Record Detail. Return to previous page, Save: Title: Estrogen and progesterone
replacement therapy reduces glucocorticoid-induced bone loss. ... Cited by 173 - Related articles - Cached - All 3 versions
DW Dempster, MA Arlot, PJ Meunier - Calcified Tissue International, 1983 - Springer Summary: We have compared the mean wall thick- ness (MWT) and active formation
periods (sigmafA)) of trabecular bone packets in iliac crest biopsies from 20
patients (7 male, 13 female) with cor- ticosteroid-induced osteoporosis ... Cited by 137 - Related articles - All 2 versions
E Canalis - J Clin Endocrinol Metab, 1996 - Endocrine Soc Bone remodeling is regulated by systemic hormones and locally produced factors
acting in concert to maintain bone mass (1). In the adult skeleton, bone
remodeling is a tightly controlled process that occurs in the bone surface ... Cited by 292 - Related articles - BL Direct - All 8 versions
